Search

everythinglearnresearchcommunity

for

Search:↓

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Severe acne in a young girl may indicate underlying hormonal issues.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

TRH stimulates human hair growth and extends the hair growth phase.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Men with CCCA often face delayed diagnosis and severe hair loss, highlighting the need for earlier recognition and treatment.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Managing emotional distress, obesity, insulin resistance, and high male hormones is crucial for improving well-being in women with PCOS.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Spironolactone plus finasteride works better for treating hirsutism.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Keratin is crucial for keeping skin cells healthy and its changes can lead to diseases and affect cell behavior.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.